by Ella Williams | Jun 2, 2023 | Bio Integrates, Biotech, Featured, Industry Insights, News
In its 5th year running, Bio Integrates once again stood out as an event that not only showcases innovation in the biotech space, but provides the community with practical insights regarding funding, partnering, regulations and more by bringing together stakeholders from across the sector to share real life industry experience.
“This is an event for the sector to look at where we are, who we are, and how we’re going to get through the mess that the UK healthcare sector finds itself in,” began Martino. “But we’re a resilient community, and whatever gets thrown at us we tend to come back stronger.”
by Jo Stickings | Aug 10, 2021 | Featured, News, Pharma
People, partnerships, pharma: exploring the science of innovation Pharmaceutical innovation is moving at a staggering pace. And behind every great research group driving the industry, there is also a team of collaborators, patients and experts from various backgrounds...
by Life Science Integrates | May 25, 2021 | Biotech, Featured, News
The second fully virtual Bio Integrates Conference surpassed expectations, with over 450 delegates attending animated keynote speaker sessions and panel debates, addressing this year’s conference themes of Connection, Projection and Reflection.
by Life Science Integrates | Apr 18, 2019 | Featured, News
RebelBio, is looking for ambitious science graduates, PhDs, postdocs and academics who want to commercialise their research in deep tech, health tech or biotech to help change the world.
by Life Science Integrates | Feb 15, 2019 | Featured, News
Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and healthcare sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of...
by Life Science Integrates | Feb 7, 2019 | Featured, White Paper
I recently had a meeting with a CEO to help solve his company’s pain points. He was in need of a big dose of a strong analgesic. Falling prices, suffocating complexity, poor product development, supply chain disruption, product shortages, increasing operational costs...
